about
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesisIonizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workersChronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literaturePrognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysisPurine analogues plus cyclophosphamide versus purine analogues alone for first-line therapy of patients with chronic lymphocytic leukaemiaRituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemiaAlemtuzumab for patients with chronic lymphocytic leukaemiaAlemtuzumab for chronic lymphocytic leukaemiaMonoclonal anti-CD20 antibodies for chronic lymphocytic leukaemiamiR-15 and miR-16 induce apoptosis by targeting BCL2The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemiaChromosomal rearrangements and microRNAs: a new cancer link with clinical implicationsTCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemiaManagement of Chronic Lymphocytic Leukemia in the ElderlyPI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL)Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHLUnexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesisImmunological cells and functions in Gaucher diseaseClinical implications of the molecular genetics of chronic lymphocytic leukemiaMicroRNAs in B cell development and malignancyImmunological aspects in chronic lymphocytic leukemia (CLL) developmentB cell receptor pathway in chronic lymphocytic leukemia: specific role of CC-292The pathogenesis of chronic lymphocytic leukemiaAnalysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.SF3B1 mutations in chronic lymphocytic leukemia.MicroRNA signatures in human cancersImmunity, Inflammation, and CancerIdentifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without ImmunotherapyChronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatmentmiR-15a and miR-16-1 in cancer: discovery, function and future perspectivesSmall RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesisVariation in WNT genes expression in different subtypes of chronic lymphocytic leukemiaLymphoma incidence patterns by WHO subtype in the United States, 1992-2001Idelalisib and rituximab in relapsed chronic lymphocytic leukemiaTherapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignanciesIdentification of therapeutic candidates for chronic lymphocytic leukemia from a library of approved drugsMutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractorinessMutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cellsStereotyped patterns of B-cell receptor in splenic marginal zone lymphoma
P2860
Q23917829-964E1956-CB22-45C5-B7EB-96CC56A24096Q23917919-165258AF-20E7-45E5-ABF7-5DC6351546B7Q23917969-6D27A789-DBF8-4BFF-BE2C-EAF09B8C7F7CQ24186840-0E51534F-EC3B-4A1A-A7E6-4187D1FEF25FQ24198941-FEDDC94C-B17E-41B3-B8B5-B0058B452CE5Q24203027-49540B19-476E-46C4-BA8F-E117074B5497Q24203628-455ABCFA-193A-4788-9A21-A7ACA255CD52Q24240922-CCDD9E9A-84F8-4081-9AC5-FF0C68B2696CQ24241519-B799E815-E41F-4C40-9001-C52360CF3809Q24536069-06D17396-6182-4766-8B74-3169930B7284Q24617708-AB3C3A41-38E7-41A6-8CFE-1909279BCF0BQ24683729-A1E508DD-2754-4BD0-B363-B25D78A8B6DAQ26773053-663A7F3C-3C21-48C3-90BB-9242A6413EB4Q26775983-238AF267-87CE-41FF-9C14-B681B607B0C9Q26782633-880BE9FD-FC44-4675-B1EB-7649D995E036Q26795504-BF500E31-5DDD-4501-B2EA-013FF9D0B067Q26822486-510E152B-4F2F-42D9-A978-72BE3B08055BQ26827675-91D5152C-49C9-4C1F-B79E-EB4868F130BEQ26830955-EC950549-65AA-4335-A580-E420EA7D66A9Q26862811-6916701A-4BE1-4B62-9BBC-E61A316EBA34Q26865940-F75E340A-A747-40E0-94E4-150B57E631F7Q27009550-48955889-5838-4828-8D91-DD98C835CE99Q27025715-64C14A0E-D316-40D9-BEF3-ECEBBE63124CQ27851655-03FAC59C-4F80-45BD-8C18-74778EBE5C9EQ27851685-9AA291C7-6047-4C9C-BFAD-AD78C82A939FQ27852162-7B77E463-8CED-4D7D-B4AF-1BEEBC701259Q27860962-E8B3E472-D85B-48DC-B18D-3B5A3E412E26Q27861048-A2FBA474-02BC-43F8-9A78-3ED8BE967B37Q28077136-D656938A-2AC0-4278-B95A-3EAFC7FA120CQ28082086-11EB3722-9881-43BB-B01A-540A93C058BFQ28247489-FE7FB5FC-C058-4AFC-8099-19412C3A64E0Q28256626-EA8820EE-0804-46EB-8133-8D677CCBD9CDQ28262745-A1BF775F-A22A-43B1-BE20-7FC341D7B170Q28271344-FFEAC72C-BDD4-4F0F-8A9A-080BAA79434BQ28306347-6F1BCA02-F056-476C-BB0C-1C83AC9A817EQ28478591-31400466-5414-401D-A2F9-9D6992F7C1F1Q28533669-EF31754C-C41F-4C71-AB33-34AB6D8C1C47Q29013141-B7A8584A-E4B0-4DC0-9F6D-4636DEA50B7AQ29048163-4ABBDD25-0830-473C-BDC0-0605379FF627Q29048186-47006CC6-5F95-4200-B810-BDA5AAF7FC01
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Chronic lymphocytic leukemia
@ast
Chronic lymphocytic leukemia
@en
Chronic lymphocytic leukemia
@nl
type
label
Chronic lymphocytic leukemia
@ast
Chronic lymphocytic leukemia
@en
Chronic lymphocytic leukemia
@nl
prefLabel
Chronic lymphocytic leukemia
@ast
Chronic lymphocytic leukemia
@en
Chronic lymphocytic leukemia
@nl
P3181
P356
P1476
Chronic lymphocytic leukemia
@en
P2093
Kanti R Rai
Nicholas Chiorazzi
P304
P3181
P356
10.1056/NEJMRA041720
P407
P577
2005-02-01T00:00:00Z